[1] SARAH F K,CATHERINE W,MAY M,et al.Cervical cancer prevention and treatment research in Africa:a systematic review from a public health perspective[J]. BMC Womens Health,2016,16(4):29. [2] 杨英梅,池宏波,顾婉红,等. 台州市女性人乳头瘤病毒感染水平分析[J]. 预防医学,2018,30(7):741-742,745. [3] 周慧娟,陈瑶瑶,王悠清,等. 浙江省肿瘤医院2013—2016年恶性肿瘤新发首诊住院病例疾病谱分析[J]. 预防医学,2018, 30(11):1148-1151. [4] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424. [5] CHEN W Q,SUN K X,ZHEN R S,et al.Cancer incidence and mortality in China,2014[J]. Chin J Cancer Res,2018,30(1):1-12. [6] 刘慧强. 我国宫颈癌流行病学特征和高危因素分析[J]. 中国妇幼保健,2016,31(6):1258-1260. [7] NDIZEYE Z,BROECK D V,VERMANDERE H,et al.Knowledge and practices of general practitioners at district hospitals towards cervical cancer prevention in Burundi,2015:a cross-sectional study[J]. Global Health,2018,14(2):4. [8] HOSNEDLOVA B,KEPINSKA M,SKALICKOVA S,et al.Nano-selenium and its nanomedicine applications:a critical review[J].Int J Nanomedicine,2018,10(13):2107-2128. [9] 陶萍萍,卞美璐,欧华,等. 导流杂交基因芯片技术在人乳头状瘤病毒检测中应用的研究[J]. 中华妇产科杂志,2006,41(1):43-47. [10] KURMAN R J,CARCANGIU M L,HERRINGTON C S,et al.WHO classification of tumours of female reproductive organs[M].4th.Lyon:IARC Press,2014:121-154. [11] FAN C D,FU X Y,ZHANG Z Y,et al.Selenocysteine induces apoptosis in human glioma cells:evidence for TrxR1-targeted inhibition and signaling crosstalk[J]. Sci Rep,2017,7(25):64-65. [12] 荣,侯春丽,王爱玲,等. hTERC基因与宫颈癌患者病理特征的关系[J]. 临床医学研究与实践,2018,3(28):10-11. [13] 陈光治,王晓娟,何燕,等. FOXM1、hTERC与C-myc在HPV阳性宫颈癌筛查意义[J]. 中国计划生育学杂志,2018,26(3):198-201. [14] YANG H,ZHANG H Y,ZHONG Y H,et al.Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer[J]. Sci Rep,2017,7(4):416-420.